Introduction
PLUNKETT'S BIOTECH & GENETICS INDUSTRY ALMANAC 2003-2004, the second edition of our guide to the biotech and genetics field, is designed as a
general source for researchers of all types.
The data and areas of interest covered are intentionally broad, ranging from the costs and effectiveness of biotech and genetics engineering and
research, to emerging technology, to an in-depth look at the 400 major firms (which we call "THE BIOTECH & GENETICS 400") within the
many sectors that make up the biotech and genetics industry.
This reference book is designed to be a general source for researchers. It is especially intended to assist with market research, strategic
planning, employment searches, contact or prospect list creation (be sure to see the export capabilities of the accompanying CD-ROM that is available
to book and eBook buyers) and financial research, and as a data resource for executives and students of all types.
PLUNKETT'S BIOTECH & GENETICS INDUSTRY ALMANAC takes a more rounded approach for the general reader. This book presents a complete overview of
the biotech and genetics field (see "How To Use This Book"). For example, stem cells and tissue engineering are discussed, as well as the
recent overall drop in biotech financing, the outlook for manufacturers of related drugs and medical products within the scope of the industry.
THE BIOTECH & GENETICS 400 is our unique grouping of the biggest, most successful corporations in all segments of the biotech and genetics
industry. Tens of thousands of pieces of information, gathered from a wide variety of sources, have been researched and are presented in a unique form
that can be easily understood. This section includes thorough indexes to THE BIOTECH & GENETICS 400, by geography, industry, sales, brand names,
subsidiary names and many other topics. (See Chapter 4.)
Especially helpful is the way in which PLUNKETT'S BIOTECH & GENETICS INDUSTRY ALMANAC enables readers who have no business background to
readily compare the financial records and growth plans of biotech and genetics companies and major industry groups. You'll see the mid-term financial
record of each firm, along with the impact of earnings, sales and strategic plans on each company's potential to fuel growth, to create new
technologies and to provide lucrative and lasting investment and employment opportunities.
No other source provides this book's easy-to-understand discussions of growth, expenditures, technologies, corporations, research and many other
items of great importance. The information within is crucial to people of all types who may be studying this, one of the newest, most dynamic and most
exciting industries in the world today.
By scanning the data groups and the unique indexes, you can find the best information to fit your personal research needs. The best major growth
companies in biotech and genetics are profiled and then ranked using several different groups of specific criteria. Which firms are the biggest
employers? Which biotech and genetics companies earn the most profits? These things and much more are easy to find.
In addition to individual company profiles, an overview of biotech and genetics technology and trends is provided. This book's job is to help you
sort through easy-to-understand summaries of today's technologies, pharmaceuticals and trends in a quick and effective manner.